Cancer-Related Cognitive Impairment in Patients With Lung Cancer
CRCI affected one-third of our patients with SCLC at diagnosis while chemobrain was uncommon and primarily associated with tobacco use. These findings underscore the role of early biomarkers in predicting CRCI and its persistence in patients with SCLC.
Authors
- Guillem Olivé (ORCID: https://orcid.org/0000-0002-8244-6369)
- Ernest Nadal (ORCID: https://orcid.org/0000-0002-9674-5554)
- Francesc Graus (ORCID: https://orcid.org/0000-0002-8924-8322)
- Marta Simó (ORCID: https://orcid.org/0000-0002-6787-1949)
- Lucía Vaquero (ORCID: https://orcid.org/0000-0003-0361-0771)
- Montserrat Alemany (ORCID: https://orcid.org/0000-0002-7039-4186)
- Estela Càmara (ORCID: https://orcid.org/0000-0002-3879-0496)
- Jordi Bruna (ORCID: https://orcid.org/0000-0001-6895-5047)
- Ariadna Padró‐Miquel (ORCID: https://orcid.org/0000-0002-6488-447X)
- April S. Caravaca (ORCID: https://orcid.org/0000-0001-6921-8700)
- Susana Padrones (ORCID: https://orcid.org/0000-0001-5814-921X)
Institutions
- Universidad Complutense de Madrid (ES)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Institut Català d'Oncologia (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Neurology
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1212/wnl.0000000000213651
- Citations
- 3
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 4.56